Pentosan polysulfate (PPS) is a polysulfated glycosaminoglycan derived from beechwood that is primarily studied for its therapeutic potential in various conditions, including interstitial cystitis and osteoarthritis. Researchers observed that PPS exhibits anti-inflammatory properties and may regulate hepcidin expression, which is crucial for iron homeostasis and has implications for conditions like anemia and osteoporosis. Key findings indicate that PPS can inhibit the differentiation and function of osteoclasts, potentially benefiting bone health, and it has shown promise in mitigating renal inflammation and albuminuria progression in diabetic nephropathy models. Current research continues to explore the multifaceted roles of PPS in both preclinical and clinical settings, highlighting its potential as a novel therapeutic agent across a range of disorders.